- $267.05m
- $172.61m
- $101.02m
Annual cashflow statement for Carlsmed, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | -18.9 | -24.3 | -29.6 |
| Depreciation | |||
| Non-Cash Items | 2.17 | 2.72 | 5.27 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | -0.893 | -4.08 | -4.89 |
| Change in Accounts Receivable | |||
| Change in Inventories | |||
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Cash from Operating Activities | -35 | -50.9 | -58 |
| Capital Expenditures | -0.135 | -0.18 | -1.36 |
| Purchase of Fixed Assets | |||
| Software Development Costs | |||
| Other Investing Cash Flow Items | — | — | -24.1 |
| Purchase of Investments | |||
| Other Investing Cash Flow | |||
| Cash from Investing Activities | -0.27 | -0.36 | -51 |
| Financing Cash Flow Items | — | — | -5.46 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | 6.36 | 117 | 200 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | -14.4 | 32.9 | 45.7 |